B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Ims2186

1 PubMed studies analyzed

Research Domains

Ims2186 has been studied across 2 research domains including 🔬 Oncology, ✨ Skin & Hair. The primary research focus is 🔬 Oncology with 100% of studies addressing this area.

Loading evidence profile...

This evidence profile for Ims2186 is generated deterministically from 1 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.